English
|
中文
HOME
NEWS
EVENTS
Conference
Exhibition
Laws & Regulations
About Us
CAIVD & CPCEM
CAIVD
CPCEM
VIEW
About VIEW
Editorial Board
Contact
Search
News
Home
>
News
In Vitro Diagnostic Industry in China - POCT III
2025-06-10
2. Dry Chemical Technology The biggest difference between “dry chemistry” and traditional “wet chemistry” (i.e., solution chemistry) is the media involved in the chemical reactions. In this method, the liqui..
IVD China last week: Thermo Fisher and Biomobio, Wondfo, Randox and Realbio, BD Medical
2025-06-09
Thermo Fisher and Biomobio Sign Strategic Agreement in Spatial Imaging Thermo Fisher Scientific and Biomobio have successfully concluded a strategic cooperation agreement for the EVOS S1000..
IVD China last week: Fapon and KIVDA, Agilent and MEGAROBO, WeGoBP
2025-05-27
Fapon and KIVDA Sign Strategic Agreement to Deepen China-Korea IVD Collaboration On 23 May, Fapon Biotech signed a strategic cooperation agreement with the Korea In Vitro Diagnostics Associ..
Xi arrives in Hanoi for state visit to Vietnam
2025-04-15
Chinese President Xi Jinping arrived in Hanoi on Monday to pay a state visit to Vietnam.
AdvaMed continues pressure on White House to exempt devices from tariffs
2025-04-09
AdvaMed and nine other healthcare organizations have continued to pressure the White House to exempt medical devices and critical supplies from the Trump administration’s ongoing tariff saga.
Switzerland Global Enterprise Visits CAIVD during CIIE to Foster Sino-Swiss Collaboration in In Vitro Diagnostics
2024-11-15
At the 7th China International Import Expo (CIIE), themed "New Era, Shared Future", representatives from 152 countries, regions, and organizations gathered for national and corporate exhibitions. On 8 November, Switze..
In Vitro Diagnostic Industry in China - POCT VIII
2025-07-15
1.1 Blood Glucose The latest IDF Diabetes Atlas (2025) reports that diabetes affects 589 million adults (20-79 years) around the world in 2024, with over 4 in 10 unaware that they have the condition. Over 4 in 5..
IVD China last week: PerkinElmer, Dirui, Sinocare, Adicon, Health Gene and Biofast
2025-07-15
PerkinElmer Launches New R&D and Manufacturing Base in China On July, PerkinElmer officially inaugurated its new Taicang-based R&D and manufacturing base, global procurement center..
QuidelOrtho and BÜHLMANN Laboratories AG Announce Availability of Fecal Calprotectin (fCAL®) Turbo and Fecal Pancreatic Elastase (fPELA®) Turbo Assays on VITROS™ Systems as a MicroTip™ Partnership Assay (MPA)
2025-07-15
QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho") and BÜHLMANN Laboratories AG today announced the availability of the BÜHLMANN fCAL turbo and fPELA turbo assays on QuidelOrtho's VITROS Systems as an MPA. Both particle-enhanced turbidimetric immunoassays, the fCAL turbo assay for fecal calprotectin measurement aids in the diagnosis of inflammatory bowel disease (IBD) and its differentiation from irritable bowel syndrome, and the fPELA turbo assay for fecal pancreatic elastase aids in the determination of pancreatic insufficiency.
Waters and BD’s Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing
2025-07-15
Original from: Waters · Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters’ proven execution model · Doubles Wate..
Personalis, Tempus Expand MRD Partnership to Include Colorectal Cancer, Extend Exclusivity Deal
2025-07-14
Personalis said this week that it has extended its strategic collaboration with Tempus AI to include colorectal cancer (CRC) among the indications covered by their existing, exclusive commercialization agreement.
Claret Bioscience and Hamilton Company Partner to Automate NGS Library Prep Workflows
2025-07-14
Claret Bioscience, a pioneer in next-generation sequencing (NGS) library preparation technologies for challenging samples, and Hamilton Company, a global leader in precision laboratory automation, are proud to announce a strategic co-promotion initiative. This collaboration aims to accelerate and simplify workflows for throughput NGS library preparation by delivering validated automation protocols for ClaretBio’s SRSLY® and REALLY™ product lines on Hamilton’s NGS STAR liquid handling platforms.
China NMPA Announces New Measures to Boost High-End Medical Device Innovation and Regulatory Support
2025-07-11
The National Medical Products Administration (NMPA) of China has introduced a series of strategic measures to accelerate the development of new-quality productivity in the high-end medical device sector.
VieCure Expands Precision Oncology Ecosystem Through Strategic Partnership with Guardant Health
2025-07-11
Original from: Access Newswire VieCure Inc., pioneer of an intelligent cancer care ecosystem that democratizes precision oncology for community-based practices, today announced a strategic partnership wit..
UK Aligning Great Britain's High-Risk IVD Standards With EU Specifications
2025-07-11
The UK government said Thursday that it will align its regulations on high-risk in vitro diagnostic devices that are sold in Great Britain to align with EU specifications and repeal regulations specific to COVID-19 tests.
Total:
3335
Pages:
223
First
Prev
1
2
3
4
..
223
Next
End